Snoring Amplifies the Risk of Heart Failure and Mortality in Dialysis Patients
Authors:
- Claudia TorinoCTClaudia Torino
- Francesco Mattace-RasoFMFrancesco Mattace-Raso
- Jan L.C.M. van SaaseJSJan L.C.M. van Saase
- Graziella D'ARrigoGDGraziella D'ARrigo
- Rocco TripepiRTRocco Tripepi
- Giovanni Luigi TripepiGTGiovanni Luigi Tripepi
- Maurizio PostorinoMPMaurizio Postorino
- Francesca MallamaciFMFrancesca Mallamaci
- Carmine ZoccaliCZCarmine Zoccali
- on behalf of the PROGREDIRE Working GroupOGon behalf of the PROGREDIRE Working Group
- 12 June 2014
- journal article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 39 (6) , 536-542
Abstract
Background: Snoring, an indicator of sleep-disordered breathing (SDB), associates with all-cause and cardiovascular (CV) mortality in high-risk conditions such as chronic heart failure (HF). Because SDB and HF are exceedingly frequent in end-stage kidney disease (ESKD), we hypothesized that SDB as detected by snoring may impact upon the relationship between chronic HF and all-cause and CV mortality in these patients. Methods: We tested this hypothesis in a cohort of 827 ESKD patients, followed up for 2.3 years. Results: In this population, snoring was a strong modifier of the risk of chronic HF for all-cause and CV death. In fully adjusted Cox models, the hazard ratio (HR) associated to chronic HF for the study outcomes was highest in heavy snorers [all-cause death: HR 2.6 (95% CI 1.6-4.3, p < 0.001); CV death: HR 4.0 (95% CI 2.1-7.6, p < 0.001)], intermediate in moderate snorers [all-cause death: HR 1.6 (95% CI 1.1-2.2, p = 0.01); CV death: HR 1.8 (95% CI 1.2-2.8, p = 0.01)], and lowest and not significant in non-snorers [all-cause death: HR 0.9 (95% CI 0.6-1.6, p = NS); CV death: HR 0.8 (95% CI 0.4-1.6, p = NS)]. Conclusions: Snoring is a strong and independent effect modifier of the relationship between chronic HF and all-cause and CV mortality in ESKD. Since SDB and snoring are in part attributable to reversible pharyngeal oedema, intensified surveillance and treatment of chronic HF snorers on dialysis may translate into better clinical outcomes in this very high-risk population, an issue which remains to be tested in specifically designed clinical trials.Keywords
This publication has 30 references indexed in Scilit:
- Snoring and risk for obstructive sleep apnea among nigerians with heart failure: Prevalence and clinical correlatesHeart Views, 2013
- Snoring and Severity of Symptomatic and Asymptomatic Carotid Stenosis: A Population-Based StudySLEEP, 2012
- Clinical and polysomnographic determinants of snoringJournal of Sleep Research, 2012
- Identification of Patients with Sleep Disordered Breathing: Comparing the Four-Variable Screening Tool, STOP, STOP-Bang, and Epworth Sleepiness ScalesJournal of Clinical Sleep Medicine, 2011
- Left Ventricular Systolic DysfunctionHypertension, 2010
- Sudden Cardiac Death in End-Stage Renal Disease PatientsHypertension, 2010
- Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating: By Ewout W. SteyerbergAmerican Journal of Epidemiology, 2009
- Sleep apnea and dialysis therapies: Things that go bump in the night?Hemodialysis International, 2007
- Outcome and risk factors for left ventricular disorders in chronic uraemiaNephrology Dialysis Transplantation, 1996
- Sleep apnea syndrome in chronic renal diseaseThe American Journal of Medicine, 1989